PALISADE CAPITAL MANAGEMENT, LP - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 25 filers reported holding ANI PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$992,000
-50.3%
816,000
-54.9%
0.03%
-51.6%
Q1 2019$1,997,000
+8.9%
1,811,000
+0.1%
0.06%
-4.5%
Q4 2018$1,833,000
-1.6%
1,809,000
+2.9%
0.07%
+31.4%
Q3 2018$1,862,000
-4.3%
1,758,000
+2.3%
0.05%
-8.9%
Q2 2018$1,945,000
+18.2%
1,718,000
+14.5%
0.06%0.0%
Q1 2018$1,645,000
-5.1%
1,500,0000.0%0.06%
-5.1%
Q4 2017$1,733,000
+5.6%
1,500,0000.0%0.06%
+1.7%
Q3 2017$1,641,000
+3.5%
1,500,0000.0%0.06%
-1.7%
Q2 2017$1,585,000
-55.8%
1,500,000
-55.9%
0.06%
-32.2%
Q4 2014$3,584,0003,400,0000.09%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
CVI Holdings, LLC 9,000,000$10,149,00012.63%
TENOR CAPITAL MANAGEMENT Co., L.P. 29,751,000$33,847,0002.02%
Wellesley Asset Management 25,925$29,366,0001.76%
MANGROVE PARTNERS IM, LLC 18,779$21,455,0001.38%
Perceptive Advisors 7,500,000$8,458,0000.22%
OAKTREE CAPITAL MANAGEMENT LP 6,857,000$7,767,0000.11%
WOLVERINE ASSET MANAGEMENT LLC 5,975,000$6,769,0000.09%
PALISADE CAPITAL MANAGEMENT, LP 1,718,000$1,945,0000.06%
CAMDEN ASSET MANAGEMENT L P /CA 930,000$1,049,0000.03%
GABELLI FUNDS LLC 1,750,000$1,983,0000.01%
View complete list of ANI PHARMACEUTICALS INC shareholders